市場調査レポート

商品コード

1687496

神経障害性疼痛市場規模、シェア、成長分析：製品タイプ別、手技別、技術別、モダリティ別、購入形態別、地域別 - 産業予測 2025～2032年

Neuropathic Pain Market Size, Share, and Growth Analysis, By Type, By Product Type, By Procedure, By Technology, By Modality, By Mode of Purchase, By Region - Industry Forecast 2025-2032

出版日: 2025年03月20日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 775,496円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 907,184円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,038,872円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.32円

全表示
概要
目次

概要

サンプル依頼リストに入れる

神経障害性疼痛市場規模は2023年に26億9,000万米ドルと評価され、2024年の28億3,000万米ドルから2032年には42億8,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは5.3％で成長する見通しです。

糖尿病のような慢性疾患の有病率の上昇と高齢化は、神経障害性疼痛の罹患率増加の主な要因です。この傾向は、革新的な治療法や医薬品ソリューションの発見を目的とした重要な研究開発活動を促進し、市場成長を後押ししています。さらに、神経障害性疼痛の効果的な管理に関するヘルスケア専門家や患者の意識の高まりが、市場拡大をさらに後押ししています。市場は、製薬会社がアンメット・メディカル・ニーズを満たすために新薬や治療法を継続的に発売しているため活況を呈しており、技術革新と進化する治療戦略のダイナミックな状況を浮き彫りにしています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Pfizer Inc.（USA）
Novartis AG（Switzerland）
Eli Lilly and Company（USA）
Johnson & Johnson（USA）
GlaxoSmithKline plc（UK）
Teva Pharmaceutical Industries Ltd.（Israel）
Astellas Pharma Inc.（Japan）
Abbott Laboratories（USA）
Medtronic plc（Ireland）
Boston Scientific Corporation（USA）
Biogen Inc.（USA）
Merck & Co., Inc.（USA）
Bristol Myers Squibb（USA）
AbbVie Inc.（USA）
Grunenthal GmbH（Germany）
AstraZeneca PLC（UK）
Daiichi Sankyo Company, Limited（Japan）

結論と提言

Product Code: SQMIG35D2215

Neuropathic Pain Market size was valued at USD 2.69 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 4.28 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).

The rising prevalence of chronic conditions like diabetes and an ageing population are key factors contributing to the increasing incidence of neuropathic pain. This trend is fostering significant research and development activities aimed at discovering innovative therapies and pharmaceutical solutions, which are propelling market growth. Moreover, heightened awareness among healthcare professionals and patients regarding effective neuropathic pain management further fuels this expansion. The market remains vibrant as pharmaceutical companies persistently launch new medications and treatment options to meet the unmet medical needs associated with neuropathic pain, highlighting a dynamic landscape of innovation and evolving therapeutic strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neuropathic Pain market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neuropathic Pain Market Segments Analysis

Global Neuropathic Pain Market is segmented by Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel and region. Based on Type, the market is segmented into Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Focal Neuropathy, Automatic Neuropathy and Proximal Neuropathy. Based on Product Type, the market is segmented into Rechargeable and Non-Rechargeable. Based on Procedure, the market is segmented into Invasive and Non-Invasive. Based on Technology, the market is segmented into Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation and Respiratory Electrical Stimulation. Based on Modality, the market is segmented into Stationary and Portable. Based on Mode of Purchase, the market is segmented into Over-the-Counter Devices and Prescription-Based Devices. Based on Pain Type, the market is segmented into Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain and Coccydynia. Based on Indication, the market is segmented into Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy and Others. Based on Diagnosis, the market is segmented into Imaging, Blood Tests and Physical Examination. Based on Treatment, the market is segmented into Medications and Multimodal Therapy. Based on End User, the market is segmented into Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Research Organization and Others. Based on Distribution Channel, the market is segmented into Direct Tender, Third Party Distributor and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neuropathic Pain Market

The neuropathic pain market is significantly driven by the rising prevalence of chronic illnesses, including diabetes, various types of cancer, and neurological disorders, which has resulted in a greater incidence of neuropathic pain cases worldwide. As the global population ages, the associated risk factors for neuropathic pain are also increasing, further boosting market demand. Additionally, continuous advancements in research and pharmaceutical innovation are leading to the development of new medications and therapies specifically targeting neuropathic pain, thereby improving treatment options. Together, these factors are creating a robust environment for growth in the neuropathic pain market.

Restraints in the Neuropathic Pain Market

A significant constraint in the neuropathic pain market arises from the challenges linked to accurate diagnosis and the inherently subjective nature of pain assessment, which can hinder effective identification and measurement of neuropathic pain. This often results in underreporting or improper management of the condition. Additionally, the high costs associated with sophisticated treatment options and medications may further limit access to these therapies, particularly in regions with constrained healthcare budgets. These factors collectively hinder the growth of the market, affecting both patient outcomes and overall market dynamics in the management of neuropathic pain.

Market Trends of the Neuropathic Pain Market

The neuropathic pain market is witnessing a significant trend towards the development of innovative treatment modalities, driven by a robust focus on research and pharmaceutical advancements. This evolving landscape is catalyzed by the increasing recognition of neuropathic pain's complexities, prompting the exploration of tailored therapeutic solutions. Furthermore, the rise of telehealth and virtual healthcare platforms is transforming the diagnosis, monitoring, and management of neuropathic pain, making care more accessible and personalized. These advancements not only enhance patient engagement but also allow for real-time adjustments to treatment plans, ultimately improving outcomes and driving market growth in this dynamic sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Neuropathic Pain Market Size by Type & CAGR (2025-2032)

Market Overview
Spinal Cord Stimulation (SCS) Devices
External Peripheral Nerve Stimulation
Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Focal Neuropathy
Automatic Neuropathy
Proximal Neuropathy

Global Neuropathic Pain Market Size by Product Type & CAGR (2025-2032)

Market Overview
Rechargeable
Non-Rechargeable

Global Neuropathic Pain Market Size by Procedure & CAGR (2025-2032)

Market Overview
Invasive
Non-Invasive

Global Neuropathic Pain Market Size by Technology & CAGR (2025-2032)

Market Overview
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation

Global Neuropathic Pain Market Size by Modality & CAGR (2025-2032)

Market Overview
Stationary
Portable

Global Neuropathic Pain Market Size by Mode of Purchase & CAGR (2025-2032)

Market Overview
Over-the-Counter Devices
Prescription-Based Devices

Global Neuropathic Pain Market Size by Pain Type & CAGR (2025-2032)

Market Overview
Peripheral Neuropathy
Entrapment Neuropathy
Phantom Limb Neuropathy
Trigeminal Neuralgia
Post Herpetic Neuralgia (PHN)
Post Traumatic Neuropathy
Foot Pain
Coccydynia

Global Neuropathic Pain Market Size by Indication & CAGR (2025-2032)

Market Overview
Spinal Stenosis
Chemotherapy-Induced Peripheral Neuropathy
Diabetic Neuropathy
Others

Global Neuropathic Pain Market Size by Diagnosis & CAGR (2025-2032)

Market Overview
Imaging
Blood Tests
Physical Examination

Global Neuropathic Pain Market Size by Treatment & CAGR (2025-2032)

Market Overview
Medications
Multimodal Therapy

Global Neuropathic Pain Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Home Healthcare
Ambulatory Surgical Centers
Research Organization
Others

Global Neuropathic Pain Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Direct Tender
Third Party Distributor
Others

Global Neuropathic Pain Market Size & CAGR (2025-2032)

North America (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
- US
- Canada
Europe (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product Type, Procedure, Technology, Modality, Mode of Purchase, Pain Type, Indication, Diagnosis, Treatment, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grunenthal GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

神経障害性疼痛市場規模、シェア、成長分析：製品タイプ別、手技別、技術別、モダリティ別、購入形態別、地域別 - 産業予測 2025～2032年

Neuropathic Pain Market Size, Share, and Growth Analysis, By Type, By Product Type, By Procedure, By Technology, By Modality, By Mode of Purchase, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

神経障害性疼痛市場規模：タイプ別& CAGR（2025-2032）

神経障害性疼痛市場規模：製品タイプ別& CAGR（2025-2032）

神経障害性疼痛市場規模：手技別& CAGR（2025-2032）

神経障害性疼痛市場規模：技術別& CAGR（2025-2032）

神経障害性疼痛市場規模：モダリティ別& CAGR（2025-2032）

神経障害性疼痛市場規模：購入形態別& CAGR（2025-2032）

神経障害性疼痛市場規模：痛みの種類別& CAGR（2025-2032）

神経障害性疼痛市場規模：適応症別& CAGR（2025-2032）

神経障害性疼痛市場規模：診断別& CAGR（2025-2032）

神経障害性疼痛市場規模：治療別& CAGR（2025-2032）

神経障害性疼痛市場規模：エンドユーザー別& CAGR（2025-2032）

神経障害性疼痛市場規模：流通チャネル別& CAGR（2025-2032）

神経障害性疼痛市場規模：地域別& CAGR（2025-2032）